The Neuron-Specific Enolase Assessment in Patients with Neuroendocrine Tumors with or without Carcinoid Syndrome

#1197

Introduction: NeuroEndocrine Tumors (NETs) comprises a wide area of clinical presentations and neuroendocrine markers.

Aim(s): We focused on Neuron-Specific Enolase (NSE) assay in NETs.

Materials and methods: This is an observational study in patients with NETs, with at least 1 endocrine evaluation at C.I.Parhon National Institute of Endocrinology, Bucharest, between 2008-2014. Clinical evaluation (including the confirmation of carcinoid syndrome), neuroendocrine markers were assessed: chromogranin A (normal < 100ng/mL), serotonin (normal < 240 ng/mL), and serum NSE (normal <12ng/mL).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Carsote M, Capatina C, Terzea D, Petris R, Goldstein A,

Keywords: neuron-specific enolase, neuroendocrine tumors,